Stay updated on Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page.

Latest updates to the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov record for the cabozantinib study in advanced urothelial cancer is displayed, with study details, participant criteria, treatment and outcome information, and posted results.SummaryDifference61%

- Check14 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2. The study record remains unavailable and displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces that NIH is transitioning to use “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site footer revision advanced from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now renders a 403 Forbidden error, blocking access to the study record; the site chrome remains visible, with the 403 message shown as the main content.SummaryDifference21%

Stay in the know with updates to Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs. Chemo in Advanced Urothelial Cancer Clinical Trial page.